Welcome to our dedicated page for electroCore SEC filings (Ticker: ECOR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
electroCore, Inc. filings document the regulatory record of a commercial-stage bioelectronic medicine and wellness company focused on non-invasive vagus nerve stimulation products. Current reports include financial results, guidance, preliminary estimates, and business updates tied to prescription sales, VA channel activity, direct-to-consumer Truvaga sales, and Quell product revenue.
The filings also cover capital-structure and governance matters, including common stock issuances, resale registration obligations, board composition, executive changes, and related material-event disclosures. These records describe electroCore’s operating performance, product commercialization, financing activity, and public-company governance framework.
electroCore, Inc. (symbol: ECOR) is the issuer of record for a Form 4 filing submitted to the SEC. Lev Joshua S. reported acquisition or exercise transactions in this Form 4 filing.
electroCore, Inc. (ECOR) reported that its Co-Chief Executive Officer, President and Chief Financial Officer, Joshua S. Lev, received a grant of 55,000 restricted stock units (RSUs) of Common Stock on September 8, 2026. These RSUs vest one-third on the first anniversary of the grant date and the remaining two-thirds in equal annual installments over the following two years, subject to continued service and specified change-in-control protections. Following this award, Lev holds or is entitled to 139,889 shares and RSUs in total, including previously granted RSUs with vesting dates from December 31, 2026 through January 26, 2029.
electroCore, Inc. (ECOR) announced a leadership and governance overhaul centered on a new co-Chief Executive Officer structure. On September 8, 2026, the Board appointed Joshua S. Lev and Michael Fox as co-CEOs and Presidents, while Lev continues as Chief Financial Officer and Fox as Chief Operating Officer. Both were also added as Class III directors, expanding the Board from six to eight members, and each received 55,000 RSUs that vest over three years, along with salary increases to $540,000 and target cash bonuses set at 50% of base salary.
The Board approved an Amended and Restated Executive Severance Policy, revising “Base Compensation,” raising certain Change in Control ownership thresholds to 50%, unifying normal severance terms and increasing the CEO Change in Control severance formula to 1.5x base compensation plus target bonus. New Third Amended and Restated Bylaws significantly tighten advance notice and universal proxy (Rule 14a-19) compliance requirements, extend them to special meetings and expressly authorize co-CEOs. At the annual meeting, all three Class II director nominees were elected and shareholders approved say‑on‑pay and ratified CBIZ CPAs as auditor.
For electroCore, Inc. (ECOR), reporting person Joshua S. Lev, CFO and Interim President, reported a series of option exercises and related sales of common stock. On August 21, 24 and 25, 2026, he exercised stock options for a total of 20,000 shares of common stock at an exercise price of $4.50 per share, acquiring 20,000 shares. On the same respective dates, he then sold all 20,000 shares in open-market transactions at weighted-average prices of $10.22 (range $10.14–$10.31), $9.88 (range $9.70–$10.25) and $9.36 (range $9.29–$9.50). A footnote states that his remaining equity position includes 2,889 shares of common stock and 82,000 shares of common stock issuable under previously granted RSUs, subject to future vesting conditions.
electroCore, Inc. director Thomas J. Errico purchased 5,000 shares of Common Stock of ECOR on 2026-08-13 in an open-market or private transaction at a weighted-average price of $9.8544 per share, with individual trade prices ranging from $9.83 to $9.95.
After this purchase, Errico beneficially owns 343,332 shares, including 269,106 shares held directly, 1,296 shares held by a family trust, 11,000 shares held by a trust for his benefit, 2,218 unvested shares underlying deferred stock units, and 54,712 shares that have vested from prior deferred stock units. The Rule 10b5-1 trading plan checkbox for this transaction is not marked as being made under such a plan.
electroCore, Inc. received an updated Schedule 13G/A (Amendment No. 3) from Charles Steve Theofilos, M.D., his spouse Kathryn Theofilos, and Happy Holstein Management, LLC. The reporting group beneficially owns 938,523 shares of Common Stock, including 375,000 shares issuable upon exercise of presently exercisable warrants held by Happy Holstein Management, LLC. This position represents 9.9% of the Common Stock, calculated using 9,015,885 shares outstanding as of July 31, 2026 plus the 375,000 warrant shares. Happy Holstein Management, LLC alone reports beneficial ownership of 528,168 shares, or 5.9% of the class. In total, HH Management holds warrants for 1,551,777 shares, but 1,176,777 shares underlying these warrants are excluded from current beneficial ownership because the warrants may not be exercised above a 9.99% Beneficial Ownership Limitation.
electroCore, Inc. reported second-quarter 2026 net sales of $9.5 million, up approximately 28% year-over-year, led by U.S. prescription sales to the Veterans Affairs system and general wellness products. Quell revenue reached $1.3 million, growing about 700% versus 2025, while Truvaga revenue was $1.3 million, up 27% year-over-year but down 17% sequentially as marketing spend was reduced.
Gross profit was $8.2 million with gross margin of 86.5%. Operating expenses rose to $10.9 million, reflecting higher sales and marketing and R&D, partly offset by lower general and administrative costs. GAAP net loss narrowed to $3.1 million, or $0.33 per share, and adjusted EBITDA net loss improved to $1.8 million. Cash, cash equivalents and marketable securities totaled about $10.0 million at June 30, 2026, with the balance sheet showing a stockholders’ deficit of $2.8 million.
The company is restructuring its commercial organization, expanding sales regions, adding 1099 representatives, revising incentives, and consolidating federal contracting through Lovell Government Services to lower fees and improve scalability. Management raised full-year 2026 revenue guidance to greater than 30% growth over 2025 and expects to achieve positive adjusted EBITDA in the third quarter of 2027.
electroCore, Inc. is soliciting proxies for a fully virtual 2026 annual meeting on September 8, 2026 at 9:00 a.m. Eastern Time via www.virtualshareholdermeeting.com/ECOR2026. Stockholders of record as of July 10, 2026, holding 9,015,885 common shares, may vote.
Three proposals are up for vote: electing three Class II directors (Thomas J. Errico, M.D., James C. Theofilos and Elena Bonfiglioli) to terms expiring at the 2029 meeting; ratifying CBIZ CPAs P.C. as independent auditor for 2026; and a non‑binding “Say on Pay” advisory vote on named executive officer compensation. The Board recommends voting FOR all three proposals.
The company highlights a six‑member, classified and Nasdaq‑independent board with audit, compensation, and nominating and governance committees, an independent chair, and a risk‑oversight framework. 2025 total pay was 1,636,687 for former CEO Daniel S. Goldberger and 707,480 for CFO and Interim President Joshua S. Lev, reflecting a mix of salary, cash bonuses and equity awards. Major stockholders include several >5% holders, while directors and named executives as a group beneficially own 7.8% of outstanding shares.
electroCore, Inc. former officer and director Daniel S. Goldberger reported an open-market sale of 80,000 shares of common stock at a weighted average price of $6.80 per share. According to the filing, these shares were sold in multiple transactions at prices ranging from $6.00 to $8.52 per share between April 23, 2026 and May 26, 2026, subject to Rule 144. Following these transactions, he directly holds 211,471 shares of electroCore common stock.
electroCore, Inc. Chief Financial Officer and Interim President Joshua S. Lev reported an open-market sale of 6,667 shares of Common Stock on May 28, 2026 at a weighted average price of $9.00 per share.
After this transaction, he directly owned 84,889 shares, including 2,889 shares of Common Stock and 82,000 shares issuable under previously granted RSUs that vest over several dates through late 2029, subject to continued service and certain change-in-control conditions.